Donna Skerrett

Dr. Donna Skerrett joined Paradigm Biopharmaceutical Ltd as Chief Medical Officer in September 2019. She has 30 years’ experience in transfusion medicine and cellular therapy, and clinical and translational development. Prior appointments include Chief Medical Officer at Mesoblast (2012–2019), Director of Transfusion Medicine and Cellular Therapy at Weill Cornell Medical Center in New York (2004–2011), and Associate Director of Transfusion Medicine and Director of Stem Cell Facilities at Columbia University’s New York-Presbyterian Hospital (1999–2004). Dr. Skerrett holds educational degrees from the University of Pennsylvania (BA), the Lewis Katz School of Medicine at Temple University (MD), and the Columbia University Mailman School of Public Health (MSc). Dr. Skerrett aims to integrate mechanistic, nonclinical, and clinical data in trial design. Her interests include exploring digital and artificial intelligence applications for biotechnology and pharmaceutical development.